Actively Recruiting

Age: 18Years - 85Years
All Genders
Healthy Volunteers
ID03445585

A Resource of Blood and Other Biospecimens from Patients With Cholestatic Liver Disease and Unaffected Individuals

Led by Mayo Clinic · Updated on 2026-02-17

9150

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are creating a biobank of specimens and clinical data to help understand cholestatic liver diseases, specifically primary biliary cirrhosis/cholangitis (PBC) and primary sclerosing cholangitis (PSC). This observational study collects information to support current and future research aimed at learning how these diseases begin and progress. Participants include those diagnosed with PSC, PBC, other chronic liver diseases, and individuals without liver disease. Samples of blood, saliva, stool, and urine are collected during visits, through mail-home kits, or remote phlebotomy. Bile samples and bile duct cells are collected only during necessary clinical procedures called ERCPs at Mayo Clinic. During the study, participants provide various biological samples and clinical data. Researchers will monitor the number of participants, types of samples collected, and clinical outcomes over 20 years. This long-term observation helps develop new tests for early detection and better understanding of disease progression.

CONDITIONS

Brief Title

Biobank for Cholestatic Liver Diseases.

Who Can Participate

Age: 18Years - 85Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with primary sclerosing cholangitis (PSC) aged 18 to 85 at enrollment.
  • Diagnosis of PSC based on clinical and biochemical evidence of chronic cholestasis for at least six months, positive cholangiographic findings, and compatible liver biopsies if available.
  • Patients with PSC who have had liver transplantation may enroll except for bile collection.
  • Women with PSC who are pregnant or of childbearing potential may enroll.
  • Patients diagnosed with primary biliary cirrhosis/cholangitis (PBC) aged 18 to 85 at enrollment.
  • Diagnosis of PBC based on clinical and biochemical evidence of chronic cholestasis for at least six months, positive anti-mitochondrial antibodies, and compatible liver biopsies if available.
  • Patients with PBC who have had liver transplantation may enroll except for bile collection.
  • Women with PBC who are pregnant or of childbearing potential may enroll.
  • Controls without history of PBC, PSC, or other chronic liver disease aged 18 to 85.
  • Patients with other chronic liver diseases (not PBC or PSC) aged 18 to 85.
Not Eligible

You will not qualify if you...

  • Patients with PBC or PSC who have other overlapping chronic liver diseases.
  • Individuals unable to provide informed consent.
  • Prisoners and institutionalized individuals.
  • Patients with PSC who have had liver transplantation are excluded from bile collection during ERCP.
  • Patients with history of Roux en Y procedure are excluded from bile collection during ERCP.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Sample Collection

Duration - Up to 20 years

Participants provide blood, saliva, stool, and urine samples periodically during visits or via mail-home kits and remote phlebotomy. Bile and bile duct cells are collected during clinically necessary ERCP procedures for those undergoing these procedures.

Periodic visits and mail-home or remote sample collection

Long-term Monitoring

Duration - Up to 20 years

Participants are observed over time to collect clinical data and monitor disease progression and outcomes.

Ongoing clinical assessments during regular healthcare visits

Trial Site Locations

Total: 1 location

1

Mayo Clinic

Rochester, Minnesota, United States, 55901

Actively Recruiting

Loading map...

Research Team

E

Erik Schlicht, CCRP, B.A.

J

Jackie Bianchi

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Similar Trials

Constitution of a Biological Collection to Establish Preclin...

Chronic Liver Disease and Cirrhosis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here